Metraipolis › archive › dc_cf8a5861671c

A precision immuno-oncology turn? Hybridizing cancer genomics and immunotherapy through neoantigens-based adoptive cell therapies — Europe PMC PMID:39676262

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39676262
DOI
10.1177/03063127241303720
License (as archived)
solo-consultazione
Archived
2026-10-07T19:46:39.429Z
SHA-256 of the archived text
bedfbbf107699b491445326826152511ce21ab6c9e0213686dd046694e2a46a7
Stable URL of this page
https://metraipolis.com/documento/dc_cf8a5861671c

How to cite

A precision immuno-oncology turn? Hybridizing cancer genomics and immunotherapy through neoantigens-based adoptive cell therapies — Europe PMC PMID:39676262 — Europe PMC (en), https://europepmc.org/article/MED/39676262 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf8a5861671c (Metraipolis archive dc_cf8a5861671c, sha256 bedfbbf107699b491445326826152511ce21ab6c9e0213686dd046694e2a46a7)
BibTeX
@misc{dccf8a5861671c,
  title = {A precision immuno-oncology turn? Hybridizing cancer genomics and immunotherapy through neoantigens-based adoptive cell therapies — Europe PMC PMID:39676262},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39676262},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf8a5861671c; sha256 bedfbbf107699b491445326826152511ce21ab6c9e0213686dd046694e2a46a7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39676262. Agents can read the archived copy with the MCP tool read_document.